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Grx5 is a yeast mitochondrial protein involved in iron-
sulfur biogenesis that belongs to a recently described
family of monothiolic glutaredoxin-like proteins. No
member of this family has been biochemically charac-
terized previously. Grx5 contains a conserved cysteine
residue (Cys-60) and a non-conserved one (Cys-117). In
this work, we have purified wild type and mutant C60S
and C117S proteins and characterized their biochemical
properties. A redox potential of 175 mV was calculated
for wild type Grx5. The pKa values obtained by titration
of mutant proteins with iodoacetamide at different pHs
were 5.0 for Cys-60 and 8.2 for Cys-117. When Grx5 was
incubated with glutathione disulfide, a transient mixed
disulfide was formed between glutathione and the cys-
tein 60 of the protein because of its low pKa. Binding of
glutathione to Cys-60 promoted a decrease in the Cys-
117 pKa value that triggered the formation of a disulfide
bond between both cysteine residues of the protein, in-
dicating that Cys-117 plays an essential role in the cat-
alytic mechanism of Grx5. The disulfide bond in Grx5
could be reduced by GSH but at a rate at least 20 times
slower than that observed for the reduction of glutare-
doxin 1 from E. coli, a dithiolic glutaredoxin. This slow
reduction rate could suggest that GSH may not be the
physiologic reducing agent of Grx5. The fact that wild
type Grx5 efficiently reduced a glutathiolated protein
used as a substrate indicated that Grx5 may act as a
thiol reductase inside the mitochondria.
Glutaredoxins (Grx)1 are small proteins with thiol reductase
activity that are required for maintaining protein cysteines in
reduced form. In contrast to thioredoxins, glutaredoxins re-
quire the reduced form of glutathione, GSH, as the electron
donor (1–3). Previously characterized glutaredoxins contain an
active site that includes two conserved cysteine residues with
two non-conserved residues between them (4–6). Mutagenic
studies have shown that both residues are required for reduc-
ing protein disulfides. However, only the amino-terminal cys-
teine may be essential for the reduction of mixed disulfides of
proteins with glutathione (6–8). In Saccharomyces cerevisiae,
five different glutaredoxins have been described. Two of them
(Grx1/2) are classic dithiolic glutaredoxins containing both con-
served cysteine residues and have already been biochemically
characterized (9–11). On the basis of sequence analysis, a new
family of monothiolic glutaredoxins has been described re-
cently. These proteins are highly homologous to glutaredoxins
but contain only one cysteine residue in its putative active site
(12). Members of this family are found elsewhere, from bacteria
to mammals, including human (13). To date, none of them has
been biochemically characterized properly.
Three monothiolic glutaredoxins are found in yeast (Grx3/4/
5). No clear phenotypes have been described in yeast cells
lacking Grx3 and Grx4 and, consistent with this, no specific
role has been assigned to any of these proteins. In contrast, the
absence of Grx5 induces severe growth defects (12). Cells lack-
ing Grx5 are not able to grow on minimal medium or in the
presence of non-fermentable carbon sources; they accumulate
iron in the mitochondria and show decreased activities of iron-
sulfur-containing enzymes. These characteristics are common
to other genes involved in the synthesis and assembly of Fe-S
clusters such as SSQ1, JAC1, ATM1, NFU, YAH1, ARH1,
ISU1–2 (14), ISA1–2 (15), NFS1, YFH1 (16), and ERV1 (17).
Recently, we have shown that Grx5 is a mitochondrial protein
involved in iron-sulfur biogenesis (18).
A three-dimensional model of Grx5 was recently presented
based on the known structure of several dithiolic glutaredoxins
(13). Grx5 shows a classic thioredoxin fold structure, with the
putative catalytic cysteine (Cys-60) lying opposite to another
conserved motif that could be involved in the formation of a
glutathione cleft. Beside this motif, another non-conserved cys-
teine is found (Cys-117). Site directed mutagenesis studies
suggest that this cysteine is not essential for the biological
activity of the protein (13).
Despite these observations, there is no evidence that Grx5
works as a thiol reductase. Also, the specific role of Grx5 in
iron-sulfur biogenesis is still not clear. Shenton et al. (19)
showed that, in cells lacking Grx5, the cytosolic enzyme glyc-
eraldehyde-3-phosphate-dehydrogenase was glutathiolated,
and they suggested that Grx5 could work as a deglutathiolase.
However the recent finding that Grx5 is a mitochondrial en-
zyme (18) suggests that this glutathiolation may be related to
the oxidative stress conditions generated by iron accumulation
in grx5 cells rather than to the direct effect of Grx5, a mito-
chondrial protein, on glyceraldehyde-3-phosphate-dehydrogen-
ase, a cytosolic enzyme. In this work we address the biochem-
ical characterization of Grx5, including determination of the
cysteine pKa value and redox potential. Based on these results,
we propose a mechanism of action for the Grx5 protein. This is
the first characterization of a monothiolic glutaredoxin and
constitutes the first evidence that these proteins can work as
thioloxidoreductases.
* This work was funded by Generalitat de Catalunya Grants 2000
SGR 0042 (to J. R.) and 2001 SGR 00305 (to E. H.) and Ministerio de
Ciencia y Tecnologı´a (Spain) Grants BMC2001-0874 (to J. R.), and
BMC2001-1213-C02-01 (to E. H.). The costs of publication of this article
were defrayed in part by the payment of page charges. This article must
therefore be hereby marked “advertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed. Tel.: 34-973-702407;
Fax: 34-973-702426; E-mail: joaquim.ros@cmb.udl.es.
1 The abbreviations used are: Grx, glutaredoxin; DTNB, 5,5-dithio-
bis-2-nitrobenzoic acid; HED, -hydroxyethyl disulfide; MOPS, 4-mor-
pholinepropanesulfonic acid; MES, 4-morpholineethanesulfonic acid;
WT, wild type; HPLC, High performance liquid chromatography;
MALDI-TOF, matrix-assisted laser desorption/ionization-time of flight.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 278, No. 28, Issue of July 11, pp. 25745–25751, 2003
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 25745
 at U
N
IV
ERSITA
T D
E LLEID
A
 on June 30, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
EXPERIMENTAL PROCEDURES
Materials—GSH, GSSG, cystine, dehydroascorbate, iodoacetamide,
glutathione reductase, thioredoxin, and trifluoroacetic acid were from
Sigma. Glutaredoxin 1 (Grx1) from Escherichia coli was from Calbio-
chem, and 2-hydroxyethyl disulfide (HED) was from Aldrich. Rat car-
bonic anhydrase III was a kind gift of Dr. Rod Levine (National Insti-
tutes of Health, Bethesda, MD).
Strains and Plasmids—Plasmid pMM192 contains the GRX5 open
reading frame without the region coding from amino acids 2–29 (PCR-
amplified from S. cerevisiae genomic DNA), cloned between the NdeI
and BamH I unique sites of the E. coli expression vector pET-21a
(Novagen). Point mutations in GRX5 that yielded the different amino
acid replacements were constructed by the ExSite method (20), using
pMMM192 as template. Oligonucleotides for the introduction of the
point mutations were designated in such a way that a restriction site
that did not alter the translation product was introduced near to the
desired point mutation and used as a marker for the DNA sequencing.
Plasmids were maintained and amplified in E. coli BL21 cells
(Novagen).
Purification of Grx5 Wild Type and Mutant Proteins—E. coli cells
carrying the previously described plasmids coding for Grx5 wild type
and mutant proteins were grown at 30 °C in Luria-Bertani medium
with 100 g/ml ampicillin. When the A600 reached a value of 0.4,
expression of Grx5 was induced with 0.5 mM isopropyl thio--D-galac-
toside. After 4 h of growth, the cells were centrifuged, washed twice
with 50 mM Tris-HCl, pH 8.0, and frozen in liquid nitrogen. Purification
of the enzyme was made at 4 °C. The cells (3 g) were suspended in 5 ml
of 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, and 1 mM phenylmethane-
sulfonyl fluoride and sonicated. After centrifugation at 14,000 rpm for
30 min, the supernatant solution (5 ml, 35 mg of protein/ml) was
applied on a Sephacryl S-100 HR column (Amersham Biosciences)
equilibrated with 50 mM Tris-HCl, pH 8.0, plus 100 mM NaCl. After void
volume, 4-ml fractions were analyzed for the presence of Grx5 by
SDS-polyacrylamide gel electrophoresis. Fractions containing Grx5
were pooled and applied to a DEAE-15HR column (Waters Associates,
Milford, MA) equilibrated with 50 mM Tris-HCl, pH 8.0, and 100 mM
NaCl. After a washing step of 20 min with the same buffer, elution was
carried out by a linear gradient from 100 to 500 mM NaCl over 40 min
at a flow rate of 5 ml/min. Grx5 eluted at 300 mM NaCl. Salt was diluted
30 times by several steps of concentration/dilution of the protein using
an Amicon 8010 ultrafiltration cell. Protein was stored at 80 °C at
concentrations above 20 mg/ml. Protein was 99% pure as examined by
SDS-polyacrylamide gel electrophoresis.
Analyses—Protein concentration was determined by the Bradford
method (21). Titration of free sulfhydryl groups with 5,5-dithiobis-2-
nitrobenzoic acid (DTNB) was performed as described (22). Briefly,
20–50 g of protein were incubated for 10 min in a solution containing
200 M DTNB in 100 mM Tris-HCl buffer, pH 8.0, in a final volume of
0.1 ml. A molar extinction coefficient of 14,150 M1 cm1 was used to
calculate the number of titrated sulfhydryl groups.
Activities—Reduction of the mixed disulfide formed between HED
and glutathione (low molecular weight mixed disulfide reduction assay
or HED assay) was assayed as described in Ref. 2. Dehydroascorbate
reductase activity and glutathione peroxidase activities were performed
according to Refs. 23 and 24.
Determination of Thiol pKa Value—The rate of carboxymethylation
of Grx5 was determined by incubation of reduced Grx5 (25 M), either
wild type or mutant proteins, with 0.6 mM iodoacetamide in 23 l of 10
mM Tris, 10 mM potassium acetate, 10 mM MOPS, 10 mM MES, and 0.2
M KCl at pH values between 3 and 10. At desired incubation times, the
reaction was stopped by the addition of 2 l of 100 mM dithiothreitol.
Reduced and carboxymethylated Grx5 proteins were separated by
HPLC in a DeltaPak HPI C18 column (Waters Associates, Milford, MA).
Proteins were eluted by a linear gradient from 40 to 50% acetonitrile in
0.05% trifluoroacetic acid over 20 min at a flow rate of 0.2 ml/min.
Proteins were detected and quantified from their corresponding peak
areas at 276 nm.
Reaction of Grx5 with GSSG—Preparations (23 l) containing 25 M
of either wild type or mutant proteins in 100 mM Tris-HCl (pH 8.0)
buffer were incubated with different concentrations of GSSG at 20 °C in
sealed tubes under nitrogen. The reaction was stopped by the addition
of 2 l of 10% trifluoroacetic acid. The pH dependence of the rate of
glutathiolation was assayed under the same conditions, except that
GSSG was always present at 250 M, and Tris-HCl buffer was replaced
by a mixture containing 10 mM Tris, 10 mM potassium acetate, 10 mM
MOPS, 10 mM MES, and 0.2 M KCl at pH values between 3 and 10.
Reaction products were separated and quantified by HPLC as described
above.
Preparation of Oxidized Proteins—The fully oxidized form of WT-
Grx5 (disulfide bond) was prepared by incubation of 1 mg of reduced
protein (150 M concentration) with 0.5 mM GSSG for 30 min at 20 °C
in Tris-HCl buffer, pH 8.0. Excess glutathione was removed by size
exclusion chromatography using a PD10 column (Amersham Bio-
sciences) and concentration of the protein using a Centricon 10K (Ami-
con). After this treatment, HPLC analysis showed that 95% of the
protein was in the oxidized form (disulfide bond, see “Results”), and the
remaining 5% was in the reduced form. WT-Grx5 glutathiolated at
Cys-60 was obtained after incubation of 30 g of reduced protein (90 M
concentration) with 1 mM GSSG at pH 5.0. This preparation was sep-
arated by HPLC, and the peak corresponding to protein glutathiolated
at Cys-60 (see “Results”) was collected and dried in a Speed Vac.
Molecular Weight Determination of Modified Forms of Grx5—Peaks
obtained by incubation of Grx5 with GSSG were separated by HPLC as
described above, collected, dried in a Speed Vac, and solubilized in 20 l
of 0.1% trifluoroacetic acid. Proteins were mixed 1:1 with matrix solu-
tion (saturated 3,5-dimethoxy-4-hydroxycinnamic acid in 33% aqueous
acetonitrile and 0.1% trifluoroacetic acid). A 0.7-l aliquot of this mix-
ture was deposited onto a stainless steel MALDI probe and allowed to
dry at room temperature. Samples were measured on a Bruker Reflex
IV MALDI-TOF mass spectrometer (Bruker-Daltonics, Bremen, Ger-
many) equipped with the SCOUT source in positive ion linear mode
using delayed extraction (200 ns). A nitrogen laser (337 nm) was em-
ployed for desorption/ionization, and the ion acceleration voltage was 20
kV. The equipment was externally calibrated employing protonated
mass signals from horse cytochrome c.
Determination of the Redox Potential—The redox potential of Grx5
was determined by direct protein-protein redox equilibration (25).
Briefly, 300 l of a preparation containing 50 M reduced S. cerevisiae
Grx5 and 50 M oxidized E. coli Grx1 (and vice versa) in 0.1 M sodium
phosphate buffer, pH 7.0, plus 1 mM EDTA were incubated in small
plastic tubes attached to a manifold and purged with a constant flux of
moist nitrogen. At different times, 23 l of the preparation were re-
moved through the septum of the tubes using a degassed 25-l Hamil-
ton gas-tight syringe and mixed with 2 l of 10% trifluoroacetic acid to
stop the reaction. Protein mixtures were analyzed by HPLC as de-
scribed above, except that a linear gradient of 30–50% acetonitrile was
used.
RESULTS
Expression and Purification of Grx5 Proteins—In a previous
work we had shown that Grx5 isolated from yeast cells was a
processed form lacking the first 29 amino acids cleaved during
import of the protein into mitochondria (18). To obtain enzymes
resembling as much as possible the mature form of Grx5, all
proteins used in this study were prepared without their mito-
chondrial targeting signals. It should be noted, however, that
for a better comprehension and comparison with previous ar-
ticles, original sequence number positions have been main-
tained throughout the text. The wild type and mutant Grx5
proteins were overexpressed in E. coli cells and purified by a
two-step method that includes size exclusion and ionic ex-
change chromatography. The resulting proteins were 99%
pure and showed an apparent molecular mass of 15.5 kDa. The
same size was determined for the mature form present in yeast
extracts detected by Western blot (18). The theoretical mass of
the protein (13,478 Da) was used for the determination of the
molar concentration of the proteins. After purification, proteins
were obtained in reduced form, as indicated by cysteine titra-
tion with DTNB (Table I).
Grx5 Is Not Active in the HED Assay—Several reactions can
be catalyzed by dithiolic glutaredoxins. The most widely used
form to asses glutaredoxin activity is the glutathione:HED
transhydrogenase assay. In this assay, glutaredoxin catalyzes
the reduction of a mixed disulfide between glutathione and
HED (2). Dithiolic glutaredoxins lacking one of the two con-
served cysteines are still capable of catalyzing this reaction (6).
Glutaredoxin activity of WT Grx5, C117S Grx5, and C60S Grx5
was assayed with the HED assay. No activity could be detected
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even when a wide range of pH values (7–9.5) and GSH concen-
trations (0.6–40 mM) were used. Additionally, dehydroascor-
bate reductase and glutathione peroxidase activities, which
have been described for dithiolic glutaredoxins (23, 24), were
also tested. None of the Grx5 variants showed detectable ac-
tivity in these assays.
Determination of Cys-60 and Cys-117 pKa Value—Reactivity
of thiol groups in proteins depends highly on its pKa value.
Active cysteines from dithiolic glutaredoxins have pKa values
close to 4 (9, 26, 27). To determine the pKa value of both
cysteine residues in Grx5, we measured the rate of alkylation of
Grx5 with iodoacetamide at different pHs. This reaction occurs
only when cysteines are in the ionized thiolate anion state (28).
Thus, reduced WT, C117S, and C60S Grx5 proteins were incu-
bated with 0.6 mM iodoacetamide at pH values between 3 and
11. Reaction was stopped at different times by the addition of
10 mM dithiothreitol, and samples were analyzed by HPLC.
The concentrations of reduced (Grx5red) and carboxymethyl-
ated glutaredoxin (Grx5cmc) were calculated from the peak area
of the HPLC profile (shown in Fig. 1A). Plots of 1/[Grxred]
versus time yielded straight lines, indicating that the reaction
of iodoacetamide with Grx5 follows a second order reaction
with a single rate constant. The second order rate constants
were calculated according to Equation 1,
Kapp  [Grx5cmc]/(t  [Grx5o]  [Grx5red]) (Eq. 1)
and plotted against pH (Fig. 1B) ([Grx0] initial concentration
of Grx5). Reaction rates showed a sigmoidal dependence on pH
value at pH values of 5 (WT and C117S) and 8 (WT and
C60S). From these data it can be deduced that the increases in
reaction rates at low and high pH were respectively a conse-
quence of the ionization of Cys-60 and Cys-117. Using the
Henderson-Hasselbalch equation (28, 29), thiol pKa values of
5.0 0.1 and 8.2 0.1 were calculated for Cys-60 and Cys-117,
respectively (Table I).
Reaction of Grx5 with GSSG—Reactivity of reduced Grx5
with GSSG was tested at pH 8.0 in 0.1 M Tris-HCl buffer,
because mitochondrial pH is close to this value (30). WT Grx5
was incubated with increasing concentrations of GSSG for 15
min at 20 °C, and the products of the reaction were separated
by HPLC. Fig. 2A shows that four new peaks corresponding to
oxidized forms of the protein appeared. When the mutant pro-
teins were incubated with GSSG, only one new peak appeared
(Fig. 2, B and C). The characterization of these peaks is sum-
marized in Table II. From mass spectrometry data it can be
deduced that two additional glutathione molecules were pres-
ent in peak 1 compared with peak 5 (reduced form), whereas
only one additional glutathione molecule was present in both
peak 3 and peak 4. Peak 1 corresponded to a protein glutathio-
lated at both cysteines, whereas peak 2 was a protein present-
ing a disulfide bond between both cysteines. This was deduced
from the following observations. (i) No free thiols were detected
when the peak 2 protein was incubated with DTNB. (ii) Peak 2
presented a mass of 13,484 Da (as the reduced form). (iii) Peak
2 was also the major peak obtained when reduced Grx5 was
incubated with several oxidants such as H2O2, cystine, or oxi-
dized proteins. (iv) Peak 2 was the end product obtained either
from peak 3 or peak 4 when these peaks were collected, dried,
and solubilized at pH 8.0; and (v) reduced Grx5 (peak 5) was
obtained by incubation of peak 2 with dithiothreitol. Concern-
ing the monoglutathiolated forms of the protein, our results
indicate that peak 3 corresponded to a protein glutathiolated at
Cys-60, whereas peak 4 corresponded to a protein glutathio-
lated at Cys-117. According to the pKa values previously cal-
culated for Cys-60 and Cys-117, the pH dependence of the
appearance of peaks 3 and 4 was consistent with this assump-
tion (Fig. 3A). This was confirmed by analyzing the rate of
glutathiolation of C117S and C60S mutant proteins at different
pHs (Fig. 3B).
One interesting result was the observation that the rates of
carboxymethylation and glutathiolation did not follow the
same pH dependence in the WT protein, although in mutant
proteins they were nearly the same (compare Figs. 1 and 3).
Thus, introduction of the first glutathione in the WT protein
may increase the reactivity of the Cys-117. This suggested the
idea that one glutathione molecule could be transferred from
Cys-60 to Cys-117 in the wild type protein during the reaction,
and glutathiolation of Cys-117 would be an intermediate step
before formation of the disulfide bond. To test this hypothesis
peak 4 was collected, dried, rehydrated with Tris-HCl buffer at
pH 8.0, and incubated at 4 °C. Fig. 4 shows the percentage of
each peak found at different incubation times as determined by
HPLC analysis. It can be observed that peak 3 appeared mainly
at short incubation times, as would be expected for an inter-
mediary product of the transformation of peak 4 to peak 2.
Finally, it should be noted that the presence of both cysteines
resulted in a higher reactivity of the protein toward GSSG.
When WT Grx5 and mutant proteins were incubated for 15 min
at 20 °C with increasing GSSG concentrations at pH 8.0, oxi-
TABLE I
Biochemical characterization of Grx5 proteins
Protein Freecysteinesa
pKa value 50%
oxidationb
Redox
potentialcCys-60 Cys-117
mM
WT 2.2 0.098 175  3 mV
C60S 1.1 8.2  0.1 1.34
C117S 1.2 5.0  0.1 0.206
a Number of free cysteine residues after purification, determined with
DTNB.
b GSSG concentration producing oxidation of half of the protein after
incubation with Grx5 for 30 minutes at 20°C at pH 8.0.
c Redox potential determined by direct equilibria with Grx1 from
E. coli.
FIG. 1. Determination of thiol pKa values of Grx5. A, separation
by HPLC of reduced and carboxymethylated WT Grx5 protein. B, pH
dependence of the second order rate constant (kapp) of the reaction
between reduced WT (), C60S (), and C117S (Œ) Grx5 proteins and
iodoacetamide. The second order rate constant was calculated using
Equation 1.
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dation of half of the WT protein required 99 M GSSG, whereas
oxidation of half of the C117S and C60S mutant proteins re-
quired GSSG concentrations of 206 M and 1.34 mM, respec-
tively (Fig. 2D). These results reinforced the idea that interac-
tion between both cysteines occurred and that the presence of
Cys-117 enhanced Grx5 reactivity. Nevertheless reactivity of
Cys-117 alone (in the C60S protein) was very poor.
Reduction of Grx5 by GSH—On the basis of their results
with Plasmodium falciparum GLP1 monothiolic glutaredoxin,
Rahlfts et al. (31) suggested that GSH was unable to reduce
monothiolic glutaredoxins. This fact would explain the absence
of activity of both Grx5 and GLP1 in the HED assay. From the
above results it was clear that GSSG strongly reacted with
Grx5, promoting the formation of a disulfide bond between both
cysteines of the protein. To study whether this disulfide bond
could be reduced by GSH, oxidized Grx5 was prepared by
incubating 1 mg of protein with 0.5 mM GSSG for 30 min as
described under “Experimental Procedures.” This preparation
was incubated with increasing amounts of GSH for 15 min at
20 °C. Reduction of half of the protein required 1.4 mM GSH
(Fig. 5A). In addition, we compared the rate of reduction of the
oxidized Grx5 with that of Grx1 from E. coli, a dithiolic glu-
taredoxin active on the HED assay. Both proteins were incu-
bated at fixed concentrations of 1 and 2 mM GSH for different
times. Fig. 5B shows that, even at the shorter incubation times
(30 s), the reaction of Grx1 with GSH reached equilibrium. On
the other hand, the reaction of Grx5 with GSH required 1 h to
reach equilibrium. Thus, the reduction rate of Grx5 was at
least 20 times slower than that of Grx1. These results indicated
that reduction of Grx5 by GSH can be a limiting step for its
thiol reductase activity. The absence of detectable HED activity
in monothiolic glutaredoxins may thus be related to the ineffi-
cient reduction of these proteins.
Determination of the Redox Potential of Grx5—The redox
potential of Grx5 was determined by direct protein-protein
equilibration with E. coli Grx1 (25). Reduced Grx5 and oxidized
Grx1 were incubated at 25 °C under anaerobic conditions.
TABLE II
Biochemical characterization of peaks obtained after incubation of
Grx5 with GSSG
Protein Retentiontimea Mass
b Free
cysteinesc Redox state
d
WT
Peak 1 21.2 14,093 0.0 Diglutathiolated
Peak 2 22.6 13,483 0.0 Disulfide bond
Peak 3 23.6 13,779 0.75 Cys-117
glutathiolated
Peak 4 31.4 13,779 0.78 Cys-60
glutathiolated
Peak 5 34.4 13,484 1.58 Reduced
C60S
Peak 1 27.8 13,763 0.0 Glutathiolated
Peak 2 34.2 N.D.e 0.85 Reduced
C117S
Peak 1 25.6 13,762 0.0 Glutathiolated
Peak 2 27.6 N.D. e 0.79 Reduced
a Retention time in minutes.
b Masses in daltons, as determined by mass spectrometry.
c Number of free thiols determined with DTNB after collecting, dry-
ing, and solubilizing the corresponding peak in Tris-HCl buffer, pH 8.0.
d Redox state of the corresponding Grx5 protein. A difference of 305
and 610 Da would be expected upon addition of one and two glutathione
molecules, respectively.
e Not determined. FIG. 3. pH dependence of the rate of glutathiolation of Grx5.
Reduced WT and mutant proteins were incubated with 250 M GSSG at
different pHs for 5, 10, and 15 min, and the concentration of each
product of the reaction was determined by HPLC. The rate of formation
of the glutathiolated and oxidized forms of the WT protein is shown in
panel A, whereas that of the glutathiolation of the C60S () and C117S
() proteins is shown in B. The different symbols in panel A correspond
to peak 1 (), peak 2 (E), peak 3 (Œ), peak 4 (), and the sum of these
four peaks (f) (see also Fig. 2A).
FIG. 2. Reaction of reduced Grx5
with glutathione disulfide. Reduced
WT and mutant Grx5 proteins were incu-
bated with increasing GSSG concentra-
tions for 15 min at 20 °C in Tris-HCl
buffer, pH 8.0. The HPLC separation pro-
files of the products of the reaction of WT
Grx5 with 62.5 M GSSG (A), C60S Grx5
with 500 M GSSG (B), and C117S-Grx5
with 500 M GSSG (C) are shown. The
reduced fraction of WT (Œ), C60S (f), and
C117S () Grx5 proteins at each GSSG
concentration is shown in D.
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HPLC separation and quantification of the four protein species
was performed after incubation for 1, 2, 4, 8, and 12 h (Fig. 6).
The redox equilibrium was obtained after 4 h of incubation as
indicated by a stable ratio of the four protein species. The same
results were obtained when oxidized Grx1 and reduced Grx5
were used as the starting material. As shown in Equation 2,
E°Grx5
 E°Grx1  (RT/nF)ln([Grx5ox][Grx1red]/[Grx5red][Grx1ox]) (Eq. 2)
the standard state redox potential of Grx5 at 25°C (E°Grx5) was
calculated from a Nernst equation. The standard redox poten-
tial of E. coli Grx1 is 233 mV (25). Analysis of different
mixtures of oxidized and reduced Grx5 and Grx1 resulted in an
standard redox potential of 175  3 mV for Grx5. This result
placed Grx5 in an intermediate position among thiol-disulfide
oxidoreductases. Members of this family show very diverse
redox potentials that range from the oxidizing 124 mV of
E. coli DsbA to the strong reducing 270 mV of E. coli thiore-
doxin (25).
Reduction of Mixed Disulfides in Proteins by Grx5—To test
whether Grx5 could participate in the deglutathiolation of cys-
teine residues, rat carbonic anhydrase III was used as a sub-
strate. This protein contains five cysteines. Two of them, Cys-
186 and Cys-181, can be easily glutathiolated in vitro when
purified protein is incubated with GSSG (32). Glutathiolation
has also been described to occur in vivo (33, 34). A mutant
carbonic anhydrase with cysteine 181 substituted for serine
was used for this study. When this mutant protein is incubated
with GSSG, only cysteine 186 becomes glutathiolated.2 Re-
duced and monoglutathiolated carbonic anhydrase were easily
separated by HPLC. Furthermore, these forms of carbonic an-
hydrase did not interfere in the chromatographic separation
with any of the forms of Grx5. The glutathiolated form of
C181S carbonic anhydrase was prepared by incubating the
purified protein with 250 M GSSG for 3 h at 37 °C. Excess
glutathione was removed by extensive dialysis against 50 mM
Tris-HCl buffer, pH 7.5. Equimolar amounts of reduced WT
Grx5 and glutathiolated carbonic anhydrase were incubated at
20 °C and separated by HPLC in a C18 column (Fig. 7A). As
shown in Fig. 7B carbonic anhydrase was deglutathiolated in a
time-dependent manner. Grx5 was converted to the complete
oxidized form (disulfide bond). The same experiment was per-
formed with C117S and C60S Grx5 proteins. Both mutants
were almost unable to reduce carbonic anhydrase.
DISCUSSION
Grx3, 4 and 5 from S. cerevisiae were the first members of a
new family of proteins with glutaredoxin signature to be de-
scribed. These proteins contain one conserved cysteine residue
at the putative active site (12), and they have been found in all
types of organisms from bacteria to humans (13). Very few of
them have been studied, and only two of them have an assigned
2 R. L. Levine, personal communication.
FIG. 4. Transfer of glutathione from Cys-60 to Cys-117. WT Grx5
glutathiolated at Cys-60, obtained as described under “Experimental
Procedures,” was incubated at 4 °C in 0.1 M Tris-HCl buffer, pH 8.0.
Reaction was stopped at different times by the addition of trifluoroace-
tic acid, and the relative amount of the different products of the reaction
was determined by HPLC separation (A). The relative amounts of
oxidized Grx5 (E) and Grx5 glutathiolated at Cys-60 () or Cys-117 (Œ)
are shown in B.
FIG. 5. Comparative analysis of the reduction of S. cerevisiae
Grx5 and E. coli Grx1 glutaredoxins by GSH. A, oxidized WT Grx5
(f) was incubated with increasing amounts of GSH for 15 min in
Tris-HCl buffer, pH 8.0, and the amount of reduced protein was deter-
mined by HPLC. B, rate of reduction of WT Grx5 (filled symbols) and
Grx1 (open symbols) when incubated at 1 mM (f and ) and 2 mM (
and E).
FIG. 6. HPLC profile of the separation of the reduced (red) and
oxidized (ox) S. cerevisiae Grx5 and E. coli Grx1. Reduced Grx5
and oxidized Grx1 were incubated for 4 h at 25 °C in 200 l of 100 mM
sodium phosphate, pH 7.0, plus 1 mM EDTA. The proteins were sepa-
rated by HPLC as described under “Experimental Procedures.”
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function. The human PICOT protein has been proposed to be a
modulator of the protein kinase C- pathway (35). We have
recently shown that Grx5 from yeast is located in the mitochon-
dria and involved in the maturation of Fe-S cluster-containing
proteins (18). The glutaredoxin-like protein GLP1 from P. fal-
ciparum has also been cloned and purified but has no specific
assigned role (31).
Despite these observations, there was no consistent biochem-
ical data supporting the involvement of monothiolic glutare-
doxins in thiol redox reactions and, consequently, no mecha-
nism of action had been proposed for the members of this
family. Bushweller et al. (6) reported that mutant dithiolic
glutaredoxins lacking the second conserved cysteine residue
were still able to catalyze the reduction of the HED-GSH mixed
disulfide. The mechanism proposed for this reaction (summa-
rized in Fig. 8A) involved the formation of a mixed disulfide
between glutathione and the cysteine located at the active site.
This mixed disulfide could be cleft by GSH, yielding reduced
glutaredoxin and GSSG. It has been suggested that monothio-
lic glutaredoxins could follow this same scheme (3). However,
this was a controversial issue. First, Rahlfs et al. (31) purified
and partially characterized PfGLP1 from P. falciparum and
concluded that it could not be reduced by GSH. However, this
was probably because PfGLP1 was already reduced after puri-
fication, as occurs with Grx5. Second, neither Grx5 nor PfGLP1
are active in the HED assay, although dithiolic glutaredoxins
lacking the C-terminal cysteine are still active in this assay
(31, 19).
The results from this work demonstrate that Grx5 is a thiol
reductase that can participate in thiol redox reactions. Several
pieces of evidence support this idea. First, Cys-60 presents a
low pKa, close to the pKa values of reactive cysteines in dithiolic
glutaredoxins (9, 26, 27); second, Grx5 has the potential to form
a mixed disulfide with glutathione with high affinity; and fi-
nally, Grx5 has the ability to reduce a glutathiolated protein
such as carbonic anhydrase, indicating that its redox potential
is low enough to act as an electron donor in redox reactions
involving oxidized proteins. We propose a mechanism of action
for the reduction of mixed disulfides by Grx5 based on the
reaction of Grx5 with GSSG (summarized in Fig. 8B). First, a
mixed disulfide will be formed between Cys-60 and glutathione.
This would induce a decrease in the Cys-117 pKa value that will
trigger the formation of a disulfide bond between both cysteines
and yield reduced glutathione. However, it is not clear how
Grx5 may be reduced in vivo, because the reduction rate of
Grx5 by GSH may not be fast enough to allow the efficient
reduction of oxidized Grx5. Thus, involvement of other mito-
chondrial reducing agent(s) in this last step should be consid-
ered in further investigations. In this context it is interesting to
note that E. coli thioredoxin efficiently reduces Grx5 (data not
shown). Finally, it should be noted that the absence of activity
of Grx5 in the HED assay may be a consequence of its ineffi-
cient reduction by GSH but also of its redox potential, which
would not be low enough to efficiently reduce the mixed HED-
GSH disulfide. The redox potential of Grx5 (175mV) is higher
than that of dithiolic glutaredoxins, which range from 198 to
233 mV (25). However, it can be low enough to reduce other
disulfide bonds, as indicated by our results with glutathiolated
carbonic anhydrase.
Another important conclusion derived from this work is the
relevance of Cys-117 for Grx5 reactivity and the formation of a
disulfide bond between both cysteine residues in the polypep-
tide chain. The influence of this cysteine residue on Grx5 reac-
tivity is clearly observed in the experiments with carbonic
anhydrase. The involvement of a second cysteine in the mech-
anism of action would allow Grx5 to perform the reduction of
disulfide bonds in proteins, increasing the number of potential
substrates. A hypothetic mechanism for this reaction, based on
FIG. 7. Reduction of carbonic anhydrase III by Grx5. Glutathio-
lated rat carbonic anhydrase III was incubated with reduced Grx5
(either wild type or mutant proteins) at 20 °C in Tris-HCl buffer, pH
8.0. A, HPLC profile of the separation of the oxidized (ox) and reduced
(red) forms of carbonic anhydrase III (CAIII) and WT Grx5 after 5 min
(dashed line) and 60 min (solid line) of incubation. B, rate of reduction
of glutathiolated carbonic anhydrase by WT Grx5 (f), C60S Grx5 (),
and C117S Grx5 (Œ).
FIG. 8. Proposed catalytic mechanism of action of Grx5. A,
mechanism of action of mutant dithiolic glutaredoxins lacking the C-
terminal cysteine in the active site, as proposed by Bushweller et al. (6).
B, proposed mechanism of reaction of Grx5 with glutathiolated pro-
teins. C, hypothetic mechanism of action for the reduction of protein
disulfide bonds by Grx5 based on the mechanism of action of dithiolic
glutaredoxins (described in Ref. 6).
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the mechanism of action of dithiolic glutaredoxins, is presented
in Fig. 8C. Another interesting point arises from the observa-
tion that Cys-117 is only conserved in about half of the mono-
thiolic glutaredoxins identified so far. As a consequence, mono-
thiolic glutaredoxins should be separated in two different
classes, depending on the presence of this second cysteine res-
idue. The relevance of this non-conserved residue is a nice
example of how a single mutation can modulate the reactivity
of a polypeptide chain and allow a member of a family of
proteins to develop new specific functions in cell metabolism.
The relevance of Cys-117 was not identified in a previous work
(13) in which the functional complementation of Grx5 by sev-
eral mutant forms of the protein (including the C117S variant)
expressed in grx5 yeast cells was investigated. Although it is
less efficient than WT Grx5, the C117S protein may display
enough activity to suppress the severe growth defects found in
a grx5 strain by the monothiolic mechanism described in Fig.
8A.
Genetic and biochemical results obtained with yeast cells
depleted in Grx5 have linked this protein to the process of
iron-sulfur assembly (18). Now it is clear that its role may be
related to its thiol reductase activity. However, its physiologi-
cal substrate remains unknown. Several steps in the process of
Fe-S assembly may require the presence of a thiol reductase.
Recent works in this field indicate that the bacterial proteins
IscU and IscA (homologous to Isa and Isu proteins in yeast)
serve as scaffolds for the assembly of iron-sulfur clusters (36,
37). The first step in this process is a sulfur transfer from the
cysteine desulfurase IscS (NifS in yeast) to IscU or IscA (38,
39). Later, iron is incorporated, and a transient [2Fe2S] center
is formed in IscA/U proteins. Although the exact mechanism is
still controversial, it seems clear that reducing the equivalents
required for this process would be provided by the formation of
a disulfide bond between two cysteines in IscA/U and/or IscS
proteins (40, 41). Grx5 would be required for the reduction of
these cysteine residues and constitute an essential enzyme for
the turnover of the whole process. Another possibility may be
that Grx5 would act as a general mitochondrial thiol reductase.
Its absence would affect the assembly of iron-sulfur centers
more dramatically than any other biological process. However,
it is important to note that Grx5 is not the most abundant thiol
reductase in mitochondria, wherein the presence of thioredoxin
3 and Grx2 have also been described (11, 42). Thus, a specific
role for Grx5 seems quite possible. Further research will deter-
mine whether this specificity is a consequence of Grx5 redox
potential or the recognition by Grx5 of specific regions in target
proteins.
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